Compound 1036
Identifiers
- Canonical SMILES:
Fc1c(Cl)cccc1-c1c(nc(C2CCCCC2)n1-c1cc(Cl)cc(c1)C(=O)NCCN1CCOCC1)-c1nnn[nH]1
- InChi:
InChI=1S/C29H31Cl2FN8O2/c30-20-15-19(29(41)33-9-10-39-11-13-42-14-12-39)16-21(17-20)40-26(22-7-4-8-23(31)24(22)32)25(27-35-37-38-36-27)34-28(40)18-5-2-1-3-6-18/h4,7-8,15-18H,1-3,5-6,9-14H2,(H,33,41)(H,35,36,37,38)
- InChiKey:
OJLITOXVSHHYEN-UHFFFAOYSA-N
External links
168318106 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MDM2-Like / P53 | 7.49 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 612.19 g/mol | |||
HBA | 10 | |||
HBD | 2 | |||
HBA + HBD | 12 | |||
AlogP | 2.20 | |||
TPSA | 113.85 | |||
RB | 7 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2011023677 | 31 | MDM2 Q00987 |
|
Biochemical assay | Time-Resolved FRET | pIC50 (half maximal inhibitory concentration, -log10) | 7.49 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4919 | Azeliragon | DB12689 | |
0.4427 | Velpatasvir | DB11613 | |
0.4291 | Selonsertib | DB14916 | |
0.4280 | N-(4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]carbonyl}phenyl)-5-fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-amine | DB07936 | |
0.4139 | Eluxadoline | DB09272 | |
0.4071 | Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine | DB02388 | |
0.4043 | Radotinib | DB12323 | |
0.4038 | Losartan | DB00678 | |
0.4036 | (S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE | DB07264 | |
0.4000 | Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine | DB03084 | |
0.4000 | N-6022 | DB12206 | |
0.3994 | Elbasvir | DB11574 | |
0.3985 | Cimicoxib | DB05095 | |
0.3978 | 4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine | DB01761 | |
0.3971 | LY-2584702 | DB12690 |